PR Domain Containing 11 (PRDM11) (C-Term) antibody

Details for Product No. ABIN184877
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms PFM8, Gm707, AA163972, 8030443D09Rik, RGD1305673
(2), (1), (1)
(10), (1), (1)
(7), (3), (1)
Methode Type Peptide ELISA
ELISA, Western Blotting (WB)
(9), (3), (2), (1), (1)
Pubmed 1 reference available
Catalog no. ABIN184877
Quantity 100 µg
374.27 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Available

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Peptide with sequence LSEGRVRSGLCGG, from the C Terminus of the protein sequence according to NP_064614.2.
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Alternative Name PRDM11
Background Synonyms: PRDM11, PR domain containing 11, PR-domain containing protein 11, PFM8
Gene ID 56981
NCBI Accession NP_064614.2
Research Area Chromatin and Nuclear Signaling, Transcription Factors
Application Notes ELISA: antibody detection limit dilution 1:32000.
Western blot: Approx 50 kDa band observed in Human Lung Carcinoma A549 cell line lysates (calculated MW of 58 kDa according to NP_064614.2). Recommended concentration: 2-3 µg/mL.
Restrictions For Research Use only
Format Liquid
Buffer Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
Preservative Sodium azide
Handling Advice Minimize freezing and thawing.
Storage -20 °C
Storage Comment Aliquot and store at -20 °C.
Supplier Images
anti-PR Domain Containing 11 (PRDM11) (C-Term) antibody ABIN184877 (2µg/ml) staining of A549 lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
General Xiao, Wilson, Gamblin: "SET domains and histone methylation." in: Current opinion in structural biology, Vol. 13, Issue 6, pp. 699-705, 2003 (PubMed).

Hosts (7), (3), (1)
Reactivities (10), (1), (1)
Applications (9), (3), (2), (1), (1)
Epitopes (2), (1), (1)
back to top